Tax limitation in pharma marketing
19-05-2006 | | kategoria: Doradztwo podatkowe
Pharma Poland News discusses tax deductibility in public and non-public pharma advertising, and ways to avoid problems arising from misallocation of marketing costs, with Tomasz Frontczak, Tax Manager with GlaxoSmithKline Pharmaceuticals, and Tomasz Ciszewski, Tax Manager in Ernst & Young’s Pharmaceutical Sector Service Group.
pobierz artykuł w formacie pliku PDF